Correlation Between Mink Therapeutics and Mars Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Mars Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Mars Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Mars Acquisition Corp, you can compare the effects of market volatilities on Mink Therapeutics and Mars Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Mars Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Mars Acquisition.

Diversification Opportunities for Mink Therapeutics and Mars Acquisition

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Mink and Mars is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Mars Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mars Acquisition Corp and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Mars Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mars Acquisition Corp has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Mars Acquisition go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Mars Acquisition

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Mars Acquisition. In addition to that, Mink Therapeutics is 2.47 times more volatile than Mars Acquisition Corp. It trades about -0.02 of its total potential returns per unit of risk. Mars Acquisition Corp is currently generating about -0.01 per unit of volatility. If you would invest  1,000.00  in Mars Acquisition Corp on September 30, 2024 and sell it today you would lose (210.00) from holding Mars Acquisition Corp or give up 21.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.17%
ValuesDaily Returns

Mink Therapeutics  vs.  Mars Acquisition Corp

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Mars Acquisition Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mars Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Mink Therapeutics and Mars Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Mars Acquisition

The main advantage of trading using opposite Mink Therapeutics and Mars Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Mars Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mars Acquisition will offset losses from the drop in Mars Acquisition's long position.
The idea behind Mink Therapeutics and Mars Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world